Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,383
datasets available to search
ShareScore release 0.9.0
Dataset results
1,383 results for “HCC”
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00397540. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT00946153. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT02128958. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
ClinicalTrials.gov study NCT01180959. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead
ClinicalTrials.gov study NCT01259024. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE)
ClinicalTrials.gov study NCT03463876. IPD Sharing: Not stated. Countries: 1. Publications: 2.
11C-acetate for Treatment Response After Radiotherapy for HCC
ClinicalTrials.gov study NCT02549755. IPD Sharing: Not stated. Countries: 1. Publications: 27.
Study of BGB-A317 in Participants With Previously Treated Unresectable HCC
ClinicalTrials.gov study NCT03419897. IPD Sharing: YES. Countries: 8. Publications: 2.
A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC
ClinicalTrials.gov study NCT03764293. IPD Sharing: NO. Countries: 13. Publications: 2.
Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC
ClinicalTrials.gov study NCT02670122. IPD Sharing: NO. Countries: 1. Publications: 1.
Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection
ClinicalTrials.gov study NCT03575806. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Loc
ClinicalTrials.gov study NCT03867084. IPD Sharing: YES. Countries: 31. Publications: 1.
A Study to Evaluate SHR-1210 in Subjects With Advanced HCC
ClinicalTrials.gov study NCT02989922. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
ClinicalTrials.gov study NCT02821754. IPD Sharing: YES. Countries: 1. Publications: 5.
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
ClinicalTrials.gov study NCT04862949. IPD Sharing: NO. Countries: 1. Publications: 24.
Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC
ClinicalTrials.gov study NCT06639971. IPD Sharing: NO. Countries: 1. Publications: 3.
Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy
ClinicalTrials.gov study NCT01755767. IPD Sharing: NO. Countries: 16. Publications: 1.
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
ClinicalTrials.gov study NCT01642186. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Huge HCC
<p>Data related to patients with huge HCC treated by liver resection or TACE</p>
IMC datasets for HCC mouse models
<p>Raw MCD files associated with published study: Profiling of mouse syngeneic HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments (<a href="https://doi.org/10.1002/hep.32707">https://doi.org/10.1002/hep.32707</a>)</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.